Clinical Research Directory

Inclusion Criteria: * Any sex, ages 19-75 years inclusively * Individuals with a history of chronic Hepatitis C (HCV) or non-alcoholic steatohepatitis (NASH). Patients with history of Hepatitis C must have completed treatment and achieved Sustained viral response at 12 weeks (SVR12). * Previous FibroScan measurement (within the last 13 months) between 8 kilopascals and 35 kilopascals. * Able to understand the informed consent form, study procedures and willing to participate in study Exclusion Criteria: * Unable to achieve SVR12 with previous antiviral treatment for HCV * Multiple (\>1) liver disease diagnoses within the past 12 months * Co-infection with another Hepatitis virus or Human Immunodeficiency Virus (HIV), last testing within past 5 years * Documented or known ascites * Documented or known portal hypertension * BMI greater than 35 kg/m2 (30 kg/m2 for optional MRE participants) * If female and of child-bearing potential: pregnant, suspected or planning to become pregnant or breast-feeding * Individuals with history of persistent ethanol abuse (alcohol consumption exceeding 2 standard drinks per day on average \[1 standard drink = 10 grams of alcohol\]) * Individuals with implanted electrical devices such as pacemakers, internal defibrillators, cochlear implants and nerve stimulators. * Individuals with surgically removed gallbladder (for optional MRE procedure only)